DEUTSCHE BANK AG\ - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 23 filers reported holding CORREVIO PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q4 2018$11,000
-93.2%
4,800
-88.1%
0.00%
Q3 2018$161,000
+30.9%
40,200
+23.3%
0.00%
Q2 2018$123,00032,6000.00%
Other shareholders
CORREVIO PHARMA CORP shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,475,000$10,981,00031.51%
Tamarack Advisers, LP 2,400,000$7,584,0003.01%
Columbia Pacific Advisors, LLC 130,709$413,0000.96%
CLOUGH CAPITAL PARTNERS L P 2,111,224$6,671,0000.58%
Worth Venture Partners, LLC 172,066$544,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 577,133$1,824,0000.27%
ARS Investment Partners, LLC 337,868$1,068,0000.19%
Rock Springs Capital Management LP 1,200,000$3,792,0000.15%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,788,032$15,130,0000.12%
PRELUDE CAPITAL MANAGEMENT, LLC 122,817$388,0000.02%
View complete list of CORREVIO PHARMA CORP shareholders